SCHEMBL6943326

SCHEMBL6943326

CC(C)C(CS(=O)(=O)N(C)CC(C)(C)Oc1ccc(Cl)cc1)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 8/20 0.41
▸ CYP1A2 P05177 3/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ PPARG P37231 3/20 0.38
▸ ABCB11 O95342 2/20 0.37
▸ TSHR P16473 2/20 0.37
▸ HTR2A P28223 2/20 0.37
▸ PMP22 Q01453 2/20 0.37
▸ FABP2 P12104 1/20 0.37
▸ SLC22A12 Q96S37 1/20 0.37
▸ CNR1 P21554 8/20 0.36
▸ TDP1 Q9NUW8 2/20 0.36
▸ USP2 O75604 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950101 0.88 MMP2 (0.41) PPARACYP1A2CYP3A4MEN1MAPT
SCHEMBL6946985 0.88 PPARA (0.38) PPARACYP1A2CYP3A4MEN1MAPT
SCHEMBL6946483 0.79 MEN1 (0.46) PPARACYP1A2CYP3A4MEN1CYP2C19
SCHEMBL6946992 0.73 PPARA (0.40) PPARACYP1A2CYP3A4MEN1MAPT
SCHEMBL6948494 0.72 MEN1 (0.43) PPARACYP1A2CYP3A4MEN1CYP2C19
SCHEMBL6947259 0.70 CYP1A2 (0.43) PPARACYP1A2CYP3A4MEN1CYP2C19
SCHEMBL6946989 0.70 PPARA (0.39) PPARACYP1A2CYP3A4MEN1MAPT
SCHEMBL7078220 0.69 MEN1 (0.45) PPARACYP1A2CYP3A4MEN1CYP2C19
SCHEMBL6947449 0.67 HRH3 (0.46) CYP1A2CYP3A4MEN1CYP2C19KMT2A
SCHEMBL14558201 0.67 KMT2A (0.46) KMT2ATSHRMAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1030836-B1 HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES HAVING MMP AND TNF INHIBITORY ACTIVITY DARWIN DISCOVERY LTD (GB) 2003-01-29 — — EP claimed
US-6187924-B1 INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TUMOR NECROSIS FACTOR-ALPHA-MEDIATED DISEASES DARWIN DISCOVERY, LTD. (GB) 2001-02-13 — — US claimed
EP-0936218-B1 BENZIMIDAZOLE DERIVATIVES MOCHIDA PHARM CO LTD (JP) 2003-04-02 — — EP disclosed
EP-1030836-B1 HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES HAVING MMP AND TNF INHIBITORY ACTIVITY DARWIN DISCOVERY LTD (GB) 2003-01-29 — — EP disclosed
US-6387938-B1 Benzimidazole derivatives MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-05-14 — — US disclosed
US-6187924-B1 INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TUMOR NECROSIS FACTOR-ALPHA-MEDIATED DISEASES DARWIN DISCOVERY, LTD. (GB) 2001-02-13 — — US disclosed
EP-1030836-A1 HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES HAVING MMP AND TNF INHIBITORY ACTIVITY Darwin Discovery Limited (GB) 2000-08-30 — — EP disclosed
EP-0936218-A1 NOVEL BENZIMIDAZOLE DERIVATIVES MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1999-08-18 — — EP disclosed
WO-1999024399-A1 HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES HAVING MMP AND TNF INHIBITORY ACTIVITY DARWIN DISCOVERY LIMITED (GB) 1999-05-20 — — WO disclosed
Send feedback